Company Filing History:
Years Active: 2020-2024
Title: Innovations by Anna Meyring-Wosten in Hemodialysis Technology
Introduction
Anna Meyring-Wosten is a notable inventor based in New York, NY (US). She has made significant contributions to the field of hemodialysis, particularly in the analysis of vascular refill during treatment. With a total of 2 patents, her work is instrumental in improving patient care in this critical area of medicine.
Latest Patents
One of her latest patents is a system for analyzing vascular refill during short-pulse ultrafiltration in hemodialysis. This method involves receiving measurements of a blood-related parameter from a patient undergoing hemodialysis. It estimates values of one or more hemodialysis treatment-related parameters by applying a vascular refill model based on the received measurements. These parameters indicate the effect of vascular refill on the patient caused by the hemodialysis. The system determines a hemodialysis treatment-related operation based on the estimated values and facilitates the performance of that operation. The vascular refill model is a two-compartment model, with one compartment corresponding to blood plasma and the other to interstitial fluid, separated by a semi-permeable membrane.
Career Highlights
Anna Meyring-Wosten is currently employed at Fresenius Medical Care Holdings, Inc., where she continues to innovate in the field of hemodialysis. Her work is characterized by a commitment to enhancing treatment methodologies and improving patient outcomes.
Collaborations
Some of her notable coworkers include Aurelio A De Los Reyes, V and Doris Helene Fuertinger. Their collaborative efforts contribute to the advancement of technologies in the healthcare sector.
Conclusion
Anna Meyring-Wosten's contributions to hemodialysis technology through her patents and work at Fresenius Medical Care Holdings, Inc. highlight her dedication to improving patient care. Her innovative approaches are paving the way for advancements in medical treatment.